Breo Ellipta is a prescription medication used to manage chronic obstructive pulmonary disease (COPD) and asthma. It contains two active ingredients: fluticasone furoate, a corticosteroid that reduces inflammation, and vilanterol, a long-acting beta-agonist that helps relax the muscles in the airways. This combination helps improve breathing and control symptoms. Breo Ellipta is typically taken once daily using a special inhaler device. Patients should follow their healthcare provider's instructions for proper use and dosage. Common side effects may include headache, throat irritation, and cough, but serious side effects should be reported to a doctor immediately.